Humanigen
ID: 5331663Humanigen is a monoclonal antibody for cancer founded in 2001.
2
Funding Rounds
$29.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ca***** Du***** | - | - | |
| Jo** Ho****** | - | - | - |
| Ra**** Bo*** | - | - | - |
| Da** Ch****** | - | - | - |
| Ro**** Ba****** | - | - | - |
| Ch**** Bu**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Humanigen has raised a total of $29m in funding over 2 rounds.
Key Insights:
- Humanigen funding round, April 2012: $17m
- Humanigen Series D round: $12m
Industries
Humanigen is active in the following industries: